AFP and hepatocellular carcinoma: (Table S5) Lastly, we performed a second PSM to match the viremic HCC with subsequent SVR and the post-SVR HCC patients by liver cirrhosis, impaired liver status, AST, ALT, creatinine, AFP, BCLC stage 0/A, curative therapy, and HCC diagnosis year yielding 80 pairs of patients with comparable characteristics.